COVID Management
Treatment:
- Yellow Card Site - for reporting adverse effects to Coronovirus treatments
- NICE Guidance for managing COVD - 19
- Assessment, monitoring and management of symptomatic COVID-19 patients in the community
- Deployment of new COVID-19 treatments (nMABs and antivirals) (160 kb)
- CMDU patient eligibility criteria (134 kb)
End of Life:
- Managing Symptoms of Covid-19 (End of Life) in Adults in Community and Non-acute Hospital Settings (Notts CCG) (282 kb)
- Is there a shortage of EOL anticipatory medicines? (31 kb)
- Should Oxygen be used in COVID related end of life? (96 kb)
- Should subcutaneous fluid be prescribed in COVID related end of life care? (67 kb)
Renal:
- Overview | COVID-19 rapid guideline: chronic kidney disease | Guidance | NICE
- Coronavirus (Covid-19) guidance for patients with kidney disease | Kidney Care UK
Respiratory:
- Overview | COVID-19 rapid guideline: severe asthma | Guidance | NICE
- Overview | COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD) | Guidance | NICE
